Augmenting the clinical utility of cefiderocol through dysregulation of bacterial metal ion homeostasis (120807)
David MP De Oliveira
1
,
Ibrahim M El-Deeb
2
,
Ruby Heaton
1
,
Hayden Whyte
1
,
Nia Bickham
1
,
Gen (Tom) Li
1
,
Arun Everest-Dass
2
,
Anuk Indraratna
2
,
Olivia Bertolla
1
,
Budi Permana
1
,
Amanda J Cork
1
,
Patrick NA Harris
3
,
Kay Ramsay
3
,
Mark B Blaskovich
1
,
David L Paterson
3
4
,
Maree T Smith
5
,
Christopher A McDevitt
6
,
Mark Von Itzstein
2
,
Brian M Forde
1
3
,
Mark J Walker
1
- Centre for Superbug Solutions, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia
- Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD, Australia
- The University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia
- Saw Swee Hock School of Public Health, National University of Singapore, Saw Swee Hock, Singapore
- School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
- Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia